COMPOUND FOR THE REDUCTION OF WHITE ADIPOSE TISSUE AND THE TREATMENT OF OVERWEIGHT AND OBESITY

Patent number:

WO22123103

No items found.

The present invention relates to beta -resorcylic acid for use in reducing the amount of white adipose tissue. The inventors have discovered that beta -resorcylic acid causes a selective reduction of white adipose tissue without affecting skeletal muscle mass. The present invention thereby allows the therapeutic use of beta -resorcylic acid in preventing the accumulation of white adipose tissue or in reducing white adipose tissue. The present invention also relates to a pharmaceutical composition, to the non-therapeutic use of beta -resorcylic acid, and to a nutraceutical composition or functional food, dietary product or nutritional supplement.

Countries:

Spain

Regions:

Andalusia

Centers:

UNIVERSIDAD DE GRANADA

Other entities:

Sectors:

Health

Subsectors:

Biotechnology, Pharmaceuticals

TRL Level:

TRL 3 – experimental proof of concept

BRL Level:

PDF Link:

Download here

Video Link:

Watch it here

Sustainable Development Goal:

Applications

- Preventive effect on hepatic steatosis (NASH) and appearance of non-alcoholic fatty liver characteristics. - Reduction of TAB without affecting the content of muscle mass. - Effect against overweight and/or obesity.

Comments

Other related patents

Health

Miniaturised diffractive analysis device without the need for marking

Countries

Spain

Health

Device for converting a surgical instrument into a spreader

Countries

Spain

Food & Agro

Health

Minimal miRNA precursors

Countries

Spain

Get back to patents directory